aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.859
+0.035 (4.19%)
Mar 9, 2026, 3:01 PM EDT - Market open

aTyr Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Revenue
0.190.240.3510.39-
Upgrade
Revenue Growth (YoY)
-19.15%-33.43%-96.60%--
Upgrade
Cost of Revenue
60.2254.3742.2942.8123.26
Upgrade
Gross Profit
-60.03-54.14-41.94-32.42-23.26
Upgrade
Selling, General & Admin
17.613.7812.9813.9810.75
Upgrade
Operating Expenses
17.613.7812.9813.9810.75
Upgrade
Operating Income
-77.63-67.91-54.92-46.4-34.02
Upgrade
Other Non Operating Income (Expenses)
3.53.894.521.060.24
Upgrade
EBT Excluding Unusual Items
-74.12-64.02-50.4-45.34-33.78
Upgrade
Pretax Income
-74.12-64.02-50.4-45.34-33.78
Upgrade
Earnings From Continuing Operations
-74.12-64.02-50.4-45.34-33.78
Upgrade
Minority Interest in Earnings
0.01-00.010.010.01
Upgrade
Net Income
-74.12-64.02-50.39-45.34-33.77
Upgrade
Net Income to Common
-74.12-64.02-50.39-45.34-33.77
Upgrade
Shares Outstanding (Basic)
9374542819
Upgrade
Shares Outstanding (Diluted)
9374542819
Upgrade
Shares Change (YoY)
25.21%38.53%88.63%48.94%108.30%
Upgrade
EPS (Basic)
-0.80-0.86-0.94-1.60-1.77
Upgrade
EPS (Diluted)
-0.80-0.86-0.94-1.60-1.77
Upgrade
Free Cash Flow
-62.06-69.18-37.44-43.53-33.27
Upgrade
Free Cash Flow Per Share
-0.67-0.93-0.70-1.53-1.74
Upgrade
Operating Margin
-40856.32%-28899.57%-15557.79%-446.79%-
Upgrade
Profit Margin
-39009.47%-27243.83%-14274.50%-436.53%-
Upgrade
Free Cash Flow Margin
-32664.74%-29440.00%-10605.10%-419.09%-
Upgrade
EBITDA
-76.96-67.21-54.33-46.17-33.54
Upgrade
D&A For EBITDA
0.660.710.590.230.48
Upgrade
EBIT
-77.63-67.91-54.92-46.4-34.02
Upgrade
Revenue as Reported
0.190.240.3510.39-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.